#305 - What You Can Learn from Measuring Everything | Dr. Michael Snyder & Mike Haney
LEVELS – A Whole New LevelShow Notes
What if we could measure the human body the way engineers monitor a jet engine? For nearly two decades, Stanford geneticist Dr. Michael Snyder has been trying exactly that. By continuously tracking everything he could possibly track in his body—genome sequencing, metabolites, wearable data, whole-body imaging—he has turned himself (and ~100 study subjects) into one of the world's largest experiments in continuous health measurement. The point wasn’t mindless biohacking. It was to answer a question: Are there clinically useful signals in all that data? This conversation suggests the answer is yes. Snyder’s experience and that of dozens of his study subjects offer some of the first real evidence that continuous measurement intelligently analyzed can reveal that you’re getting sick before you have symptoms, help find solutions to medical conditions that work for your unique biology, and help you refocus on prevention of disease rather than management.
Free course: Improve your metabolic health Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: https://levels.link/wnl
🎙️ About the Guest: Dr. Michael Snyder is the Stanford W. Ascherman Professor of Genetics and director of the Stanford Center for Genomics and Personalized Medicine, where he previously chaired the Department of Genetics for 15 years.
📍What Dr. Michael Snyder & Mike Haney discussed: 03:10 Why Dr. Snyder started measuring healthy people instead of waiting for disease 09:18 Living in the future: tracking his own biology for nearly two decades 15:02 Why "normal" isn't enough: the importance of personal baselines 22:48 Discovering his own genetically unique form of type 2 diabetes 32:06 How wearables detected illness before symptoms appeared 39:18 Whole-body MRIs, incidental findings, and why change over time matters 46:55 Why everyone has abnormalities, but not everyone has disease 55:41 The promise of metabolomics, proteomics, and continuous biological sensing 1:06:52 Why AI is essential for interpreting thousands of health signals 1:15:34 What continuous measurement could mean for preventive medicine 1:23:10 The next decade of personalized health and what's still missing
🔗 Helpful Links: Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes (Chen et al., Cell, 2012) https://www.cell.com/cell/fulltext/S0092-8674(12)00965-3 Longitudinal Multi-omics Profiling Reveals Dynamic Personal Health Status (Price et al., Nature Biotechnology, 2017) https://www.nature.com/articles/nbt.3695 The Integrative Personal Omics Profile (iPOP): A Decade of Progress in Precision Health (Snyder lab review) https://www.nature.com/articles/s41576-021-00409-3 Wearable Sensor Data and Self-reported Symptoms for COVID-19 Detection (Mishra et al., Nature Biomedical Engineering, 2020) https://www.nature.com/articles/s41551-020-00640-6 All of Us Research Program https://allofus.nih.gov/ Connect with Dr Michael Snyder: https://med.stanford.edu/snyderlab.html
Watch the conversation: https://youtu.be/eUEYmLC1CcE Find us on YouTube: https://youtube.com/levelshealth?sub_confirmation=1
👋 Who we are: Levels helps you understand your metabolic health with personalized data, expert guidance, and tools that connect your daily choices to measurable changes in your body. Our goal is to help you make better decisions about food, exercise, sleep, and long-term health.
Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health.
More from LEVELS – A Whole New Level
Heart disease is the leading cause of death, but it’s also one of the most preventable. Decades of research have established a strong causal role for LDL and other ApoB-containing particles in atherosclerosis, and we now have multiple proven ways to lower them. The harder question is how to turn that evidence into a decision for an individual person. Mike Haney talks with Johns Hopkins cardiologist Dr. Seth Martin, a co-author of the new 2026 dyslipidemia guidelines, about what the latest evidence says we should actually measure and act on. The throughline is pragmatic: lower exposure to atherogenic particles earlier and for longer, use additional tests when they can change a decision, and distinguish interesting new measurements from ones that have actually been shown to improve outcomes.
Most of NextLevel starts with a measurement problem: we can see more biology than ever, but we still have to figure out what to do with it. Bioelectronic medicine flips that sequence. We already know how to send electrical signals into the nervous system to change biology, including an FDA-approved vagus nerve treatment for rheumatoid arthritis, even though we still can’t map or read most of the individual nerve fibers carrying those signals.
Most health decisions happen before the science is settled. A study points one way, another points somewhere else, experts disagree about what matters, and even strong population-level evidence may not tell you what will happen to you.
Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong? In this episode of Next Level, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing?
Alcohol has spent the last 40 years bouncing between two health narratives: a little is good for your heart, or any amount is dangerous. The science doesn’t really support either slogan. Dr. Tim Naimi has spent decades studying the health effects of alcohol and, just as importantly, why the research is so difficult to interpret. His read of the evidence is less dramatic but more useful: there’s no good reason to start drinking for your health, very low intake may carry little measurable added risk, and risk rises as consumption does. Understanding why earlier studies made moderate drinking look protective helps explain a lot of the whiplashing headlines.